Artificial intelligence is evolving at a pace that’s leaving even experts uneasy. What began as tools for efficiency is quickly turning into systems capable of generating hyper-realistic videos, ...

Branson’s statement challenges the idea that success comes from rigidly following established frameworks. Instead, it emphasises experiential learning — the ...

Tyler has worked on, lived with and tested all types of smart home and security technology for over a dozen years, explaining the latest features, privacy tricks, and top recommendations. With degrees ...

When a global financial services firm sought Sam’s guidance, the problem seemed familiar. The firm had deployed AI tools across its business. Adoption was uneven, and the gap between teams was growing ...

India’s most advanced nuclear reactor has reached a self-sustaining stage that marks a major leap for the country’s atomic energy programme, and takes it a step closer to cutting dependence on uranium ...

We just passed a milestone in health AI that honestly, we all saw coming, but has major consequences if the data to support is left unexamined. OpenAI launched ChatGPT Health and Anthropic added ...

Are you a data-driven problem solver who thrives on optimising performance, unlocking insights, and building robust database solutions? We’re looking for a Senior SQL Developer to join a high-impact ...

Today’s companies are hiring for the wrong skills. The conversation about AI talent focuses on engineers, data scientists, and machine learning specialists. Those roles matter, but they aren’t where ...

Are you a data-driven problem solver who thrives on optimising performance, unlocking insights, and building robust database solutions? We’re looking for a Senior SQL Developer to join a high-impact ...

Unpredictable work schedules don’t just disrupt your day, they can cost you money. In New York City, officials are increasingly treating those disruptions as something employers may have to pay for.

AGOURA HILLS, Calif.--(BUSINESS WIRE)--A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage immunotherapy company developing first-in-class logic-gated therapies for solid tumors, today announced that ...